All In Biotech

Free tool

FAERS Monitor: Migranal

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020148 or its brand name (Migranal, Dihydroergotamine Mesylate). Reports on generic versions are filed under their own applications.

Reports

829

Serious

652

79% of reports

Hospitalization

139

Death reported

21

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective387
  • off label use359
  • hyperhidrosis356
  • nightmare339
  • sedation339
  • nausea338
  • product use in unapproved indication293
  • nephrolithiasis252
  • migraine79
  • treatment failure57
  • dyspnoea52
  • abdominal pain47
  • diarrhoea47
  • cough46
  • weight decreased43

Reports by year received

View as table
YearReports
200417
200516
200624
200724
200820
200915
201018
201126
201226
20132
20142
20152
20169
201718
201814
201926
202018
202164
202270
202350
2024125
202584
2026159

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,330 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
sedationSignal339332.7306.3110,469
nightmareSignal339251.0231.183,486
nephrolithiasisSignal252140.2126.434,564
hyperhidrosisSignal35670.365.024,337
product use in unapproved indicationSignal29330.027.48,281
migraineSignal7921.017.01,491
treatment failureSignal5717.513.6871
nauseaSignal33810.810.03,125
off label useSignal35910.49.63,174
drug ineffectiveSignal3877.56.92,299
abdominal painSignal475.13.9154
coughSignal464.23.1109
weight decreasedSignal433.92.991
dyspnoeaSignal522.31.839
diarrhoea471.81.418

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.